Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background Safe blood transfusion remains a challenge, and transmission of infections is always a concern. The detection of infectious diseases in blood donors ensures the safety of blood transfusion. Another challenge is the differences in blood group antigens due to the ability of clinically significant antibodies to cause adverse reactions. This study aimed to evaluate the pattern of distribution and the possible correlation of transfusion-transmitted infections (TTIs) with different blood groups. This study also aimed to evaluate the frequencies of minor blood group antigens detected on screening in a few infected blood donors. Methodology This study included replacement donors who were fit to donate blood after screening. After blood donation, tests for TTIs was done using the chemiluminescence immunoassay for hepatitis B virus (HBV)/human immunodeficiency virus (HIV)/hepatitis B virus (HCV), and rapid diagnostic kits were used for malaria and syphilis. Blood grouping was performed by IMMUCOR'S NEO IRIS instrument using commercial antisera. Samples of blood donors infected with TTIs over the study period of two months were also tested for minor antigens. Statistical analysis was done using SPSS Software, version 20 (IBM Corp., Armonk, NY, USA). Results In total, 46,549 blood donors were included, of whom 3,064 (6.6%) donors were reactive for TTIs, with the most prevalent being HBV infection (n = 1,183, 2.5%). In this study, 2.4% (n = 23) of the total B-negative blood donors were HCV reactive (χ = 4.3, p = 0.038; statistically significant), and 0.9% (n = 8) of the total B-negative blood donors were malaria reactive (Fisher's exact test = 11.06, p = 0.001; statistically significant). Blood donors with A-positive blood group were significantly associated with syphilis infection (χ = 3.86, p = 0.05). The Fyb antigen was relatively more prevalent among HIV-reactive donors (n = 24, 77.4%), while E (n = 3, 9.7%) and c (n = 13, 41.9%) antigens were relatively lesser prevalent compared to other infected donors. Similarly, malaria-reactive donors had a lower prevalence of C antigen (n = 17, 73.9%) and a higher prevalence of E antigen (n = 8, 34.8%). The most common Rh phenotype found among all the TTI-infected reactive donors was CCDee, and among the Rh-negative infected donors, ccdee was the only phenotype observed. Conclusions This study determined the regional prevalence of TTIs among blood donors and noted a significant association of B-negative blood group with HCV and malaria. This study also assessed the frequency of some minor blood group antigens among TTI-infected blood donors.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12287423PMC
http://dx.doi.org/10.7759/cureus.86626DOI Listing

Publication Analysis

Top Keywords

blood donors
36
blood
22
blood group
20
donors
17
b-negative blood
12
transfusion-transmitted infections
8
blood groups
8
blood transfusion
8
group antigens
8
aimed evaluate
8

Similar Publications

Age-related differences in donor selection priorities for allogeneic hematopoietic transplantation.

Haematologica

September 2025

Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan; Division of Hematology, Department of Medicine, Jichi Medical University, Shimotsuke.

Patient age might influence donor selection priorities in allogeneic hematopoietic stem cell transplantation (allo-HCT), due to the differences in donor age, organ function, and resistance to graft-versus-host disease between younger and older patients. We compared the transplant outcomes among human leukocyte antigen (HLA)-matched related donors (M-RDs, n=4,106), HLA 1-antigen-mismatched related donors (1MM-RDs, n=592), HLA 2-3-antigen-mismatched related donors (23MM-RDs, n=882), HLA-matched unrelated donors (M-UDs, n=3,927), HLA 1-locus-mismatched unrelated donors (1MM-UDs, n=2,474), and unrelated cord blood units (U-CBs, n=5,867) between patients aged.

View Article and Find Full Text PDF

The EBMT recommends rabbit anti-thymocyte or anti-T-lymphocyte globulin (rATG/ATLG) as GVHD prophylaxis in matched sibling donor (MSD) allogeneic hematopoietic cell transplantation (allo-HCT). However, discrepancies between recommendations and clinical practice were reflected in the EBMT survey. Therefore, we performed retrospective EBMT registry analysis from 2014 to 2021 to reinforce the real-world evidence context of rATG/ATLG impact on post-transplantation outcomes.

View Article and Find Full Text PDF

Background And Objectives: The US Food and Drug Administration guidance for cold-stored platelets (CSPs) permits storage of apheresis platelets at 1-6°C for ≤14 days. During a pilot programme, CSPs were evaluated in a large US blood centre over a 10-month period (September 2023 to July 2024) to better understand the formation of aggregates under routine use.

Materials And Methods: Platelets collected in 100% plasma were moved into cold storage within 4 h of collection and shipped to local hospitals.

View Article and Find Full Text PDF

Efficacy and safety of haploidentical hematopoietic stem cell transplantation combined with umbilical cord blood infusion in hematologic malignancies: a prospective phase II clinical trial.

Transplant Cell Ther

September 2025

Department of Hematology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; Zhejiang Provincial Clinical Research Center for Hematological disorders, Hangzhou, China; Zhejiang Key Laboratory for Precision Diagnosis and Treatment of Hematological Maligancies, Han

Background: Haploidentical hematopoietic stem cell transplantation (haplo-HSCT) offers curative potential for hematologic malignancies but is often limited by high incidences of graft-versus-host disease (GVHD), delayed engraftment, and transplant-related mortality-especially when donors are aged ≥40 years. Umbilical cord blood (UCB) infusion may mitigate these risks by promoting immune tolerance and hematopoietic recovery. However, the efficacy of this strategy in the context of older donors remains insufficiently studied.

View Article and Find Full Text PDF